420 likes | 639 Views
Medical Realities of Methamphetamine Use and Recovery. Beth Rutkowski, M.P.H. finnerty@ucla.edu Pacific Southwest Addiction Technology Transfer Center UCLA Integrated Substance Abuse Programs. Consequences to the Brain. FOOD. SEX. 200. 200. NAc shell. 150. 150.
E N D
Medical Realities of Methamphetamine Use and Recovery Beth Rutkowski, M.P.H. finnerty@ucla.edu Pacific Southwest Addiction Technology Transfer Center UCLA Integrated Substance Abuse Programs
FOOD SEX 200 200 NAc shell 150 150 DA Concentration (% Baseline) 100 100 15 % of Basal DA Output 10 Empty Copulation Frequency 50 Box Feeding 5 0 0 Scr Scr Scr Scr 0 60 120 180 Bas Female 1 Present Female 2 Present Mounts Time (min) Sample Number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Intromissions Ejaculations Source: Di Chiara et al. Source: Fiorino and Phillips Natural Rewards Elevate Dopamine Levels
Effects of Drugs on Dopamine Release COCAINE 1500 1000 500 0 METHAMPHETAMINE Accumbens 400 Accumbens DA 300 DOPAC HVA % of Basal Release % Basal Release 200 100 0 0 1 2 3hr Time After Methamphetamine Time After Cocaine 250 ETHANOL NICOTINE 250 Accumbens Dose (g/kg ip) 200 Accumbens 200 0.25 Caudate 0.5 150 % of Basal Release 1 % of Basal Release 2.5 150 100 0 1 2 3 hr 100 0 0 0 1 2 3 4hr Time After Ethanol Time After Nicotine Source: Shoblock and Sullivan; Di Chiara and Imperato
PET Scan of Long-Term Impact of Methamphetamine on the Brain
Decreased dopamine transporter binding in METH users resembles that in Parkinson’s Disease Control Meth PD Source: McCann U.D.. et al.,Journal of Neuroscience, 18, pp. 8417-8422, October 15, 1998.
2.0 Motor Activity 1.8 1.6 1.4 (Bmax/Kd) Dopamine Transporter 1.2 1.0 7 8 9 10 11 12 13 Normal Control Time Gait (seconds) 2 Memory 1.8 1.6 1.4 Dopamine Transporter Bmax/Kd 1.2 1 16 14 12 10 8 6 4 Methamphetamine Abuser Delayed Recall p < 0.0002 (words remembered) Dopamine Transporters in Methamphetamine Abusers
Cognitive and Memory Effects
Differences between Stimulant and Comparison Groups on tests requiring perceptual speed
Longitudinal Memory Performance number correct test
Control > MA 4 3 2 1 0
5 4 3 2 1 0 MA > Control
Partial Recovery of Brain Dopamine Transporters in Methamphetamine Abuser After Protracted Abstinence 3 0 ml/gm METH Abuser (1 month detox) Normal Control METH Abuser (24 months detox) Source: Volkow, ND et al., Journal of Neuroscience 21, 9414-9418, 2001.
Partial Recovery of Brain Metabolism in Methamphetamine (METH) Abuserafter Protracted Abstinence 70 0 µmol/100g/min Control Subject (30 y/o, Female) METH Abuser (27 y/o, Female) 3 months detox METH Abuser (27 y/o, Female) 13 months detox Source: Wang, G-J et al., Am J Psychiatry 161:2, February 2004.
Acute and Long-Term Effects of the Methamphetamine Abuse A Quick Review:
MethamphetamineAcute Physical Effects Increases • Heart rate • Blood pressure • Pupil size • Respiration • Sensory acuity • Energy Decreases • Appetite • Sleep • Reaction time
Increases Confidence Alertness Mood Sex drive Energy Talkativeness Decreases Boredom Loneliness Timidity MethamphetamineAcute Psychological Effects
MethamphetamineChronic Physical Effects • Tremor • Weakness • Dry mouth • Weight loss • Cough • Sinus infection • Sweating • Burned lips; sore nose • Oily skin/complexion • Headaches • Diarrhea • Anorexia
MethamphetamineChronic Psychological Effects • Confusion • Concentration • Hallucinations • Fatigue • Memory loss • Insomnia • Irritability • Paranoia • Panic reactions • Depression • Anger • Psychosis
Speed Bumps Abscesses
Faces of Methamphetamine Images courtesy Multnomah County Sheriff’s Office
Meth Mouth • Rotting of teeth around the gums • Process may involve lack of saliva production or qualities of methamphetamine or its constituents • Smoking/snorting problems • Bruxism; Rampant caries http://www.msnbc.msn.com/id/8770112/site/newsweek/
Behavioral Disruption Cognitive Disruption Emotional Disruption Family/Relationship Disruption MATRIX MODEL TREATMENT Components of Stimulant Addiction Syndrome
STAGES OF RECOVERY - STIMULANTS OVERVIEW DAY 180 DAY 0 DAY 15 DAY 45 DAY 120 Adjustment Honeymoon The Wall Withdrawal Resolution
Stages of Recovery - Stimulants WITHDRAWAL STAGE DAY 0 DAY 15 • Medical Problems • Alcohol Withdrawal • Depression • Difficulty Concentrating • Severe Cravings • Contact with Stimuli • Excessive Sleep PROBLEMS ENCOUNTERED
Stages of Recovery - Stimulants HONEYMOON STAGE DAY 15 DAY 45 • Over-involvement With Work • Overconfidence • Inability to Initiate Change • Inability to Prioritize • Alcohol Use • Episodic Cravings • Treatment Termination PROBLEMS ENCOUNTERED
Stages of Recovery - Stimulants THE WALL STAGE DAY 45 DAY 120 • Return to Old Behaviors • Anhedonia • Anger • Depression • Emotional Swings • Unclear Thinking • Isolation • Family Problems • Cravings Return • Irritability • Abstinence Violation PROBLEMS ENCOUNTERED
Stages of Recovery - Stimulants ADJUSTMENT AND RESOLUTION STAGES DAY 120 DAY 180 • Relationship Problems • Boredom • Career Dissatisfaction • Lack of Goals • Guilt and Shame • Underlying Psycho-pathology May Surface or Resurface PROBLEMS ENCOUNTERED
Successful Outpatient Treatment Predictors • Durations over 90 days (with continuing care for another 9 months). • Techniques and clinic practices that improve treatment retention are critical. • Treatment should include 3-5 clinic visits per week for at least 90 days.
Successful Outpatient Treatment Predictors • Employ evidence-based practices[i.e., CBT, CM, Community Reinforcement Approach, Motivational Interviewing, Matrix Model]. • Family involvement and 12-step programs appear to improve outcome. • Urine testing (at least weekly is recommended)
Special treatment consideration should be made for the following groups of individuals: • Female MA users (higher rates of depression; very high rates of previous and present sexual and physical abuse; responsibilities for children). • Injection MA users (very high rates of psychiatric symptoms; severe withdrawal syndromes; high rates of hepatitis). • MA users who take MA daily or in very high doses.
Special treatment consideration should be made for the following groups of individuals: • Homeless, chronically mentally ill and/or individuals with high levels of psychiatric symptoms at admission. • Individuals under the age of 21. • Gay men (at very high risk for HIV and hepatitis).
The End For more information, please contact Beth Rutkowski at 310-445-0874 x376 or finnerty@ucla.edu www.uclaisap.org or www.psattc.org